Cristina M Fischer

Title: Cristina M Fischer: Pioneering Innovations in Cancer Treatment

Introduction

Cristina M Fischer is a notable inventor located in Wadsworth, Illinois. With a keen focus on pharmaceutical innovations, she has secured two patents that contribute significantly to the field of cancer treatment. Her work reflects a dedication to developing effective therapeutic options for diseases characterized by the overexpression of anti-apoptotic Bcl-2 family proteins.

Latest Patents

Cristina's latest patents include:

1. **ABT-263 Capsule**: This pharmaceutical capsule features a shell that encapsulates a liquid solution of ABT-263 or a pharmaceutically acceptable salt within a substantially non-ethanolic carrier. The formulation includes excipients such as phospholipids, solubilizing agents, surfactants, and sulfur-containing antioxidants. This innovative capsule aims to treat diseases, particularly cancers, by targeting the overexpression of Bcl-2 family proteins.

2. **Stabilized Lipid Formulation of Apoptosis Promoter**: This orally deliverable pharmaceutical composition incorporates a Bcl-2 family protein inhibitory compound, such as ABT-263, combined with a heavier-chalcogen antioxidant in a non-aqueous lipid carrier. Designed for oral administration, this formulation holds promise for effectively treating conditions marked by the overexpression of anti-apoptotic Bcl-2 proteins, like cancer.

Career Highlights

Cristina M Fischer currently works at AbbVie Inc., a global biopharmaceutical company known for its focus on discovering and delivering innovative medicines. Her contributions to pharmaceutical science are positioned at the intersection of cutting-edge research and practical application, reflecting her commitment to improving patient outcomes.

Collaborations

Throughout her career, Cristina has collaborated with talented coworkers, including Ping Tong and Deliang Zhou. These partnerships have fostered a collaborative environment conducive to innovation, enhancing the development of therapeutic compounds aimed at fighting challenging diseases.

Conclusion

Cristina M Fischer stands out as a pioneering inventor who is making strides in the pharmaceutical industry. With her innovative patents and collaborative approach, she is contributing to the advancement of cancer treatment, aiming to provide hope and solutions for patients in need.